JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.

Employees

3,177

Sector

Drug Retailers

Calendar

2025-03-30 - Q4 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-12-04	28.85 $	-0.86%	4,140,578
24-12-03	29.10 $	+0.17%	7,202,578
24-12-02	29.05 $	+2.47%	8,297,950
24-11-29	28.35 $	+1.43%	8,848,483
24-11-28	27.95 $	+0.54%	7,594,122

Delayed Quote Hong Kong S.E., December 04, 2024 at 03:08 am EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart JD-HEALTH-INTERNATIONAL-I

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.24CNY

Average target price

32.21CNY

Spread / Average Target

+18.25%

Consensus

Profit revisions

estimates-change-chart JD-HEALTH-INTERNATIONAL-I

Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart JD-HEALTH-INTERNATIONAL-I

Company calendar

Market Closed - Hong Kong S.E. Other stock markets 03:08:13 2024-12-04 am EST			5-day change	1st Jan Change
28.85 ^HKD	-0.86%		+6.85%	-26.21%

Nov. 18	Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	MT
Nov. 14	JD Health International Records 212% Higher Profit, 15% Higher Revenue for Q3	MT

Capitalization	86.9B 92.84B 11.93B 11.35B 10.57B 9.42B 16.78B 1,010B 18.42B 131B 48.73B 414B 44.82B 43.82B 1,784B	P/E ratio 2024 *	27.6x	P/E ratio 2025 *	24.4x
Enterprise value	67.78B 72.41B 9.3B 8.85B 8.24B 7.35B 13.09B 788B 14.37B 103B 38B 323B 34.96B 34.18B 1,391B	EV / Sales 2024 *	1.17x	EV / Sales 2025 *	0.97x
Free-Float	32.24%	Yield 2024 *	-	Yield 2025 *	-

Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	Nov. 18	MT
JD Health International Records 212% Higher Profit, 15% Higher Revenue for Q3	Nov. 14	MT
JD Health International Grants Share Awards Under Post-IPO Award Scheme	Oct. 02	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	Aug. 19	MT
Hong Kong Stocks Extend Gains on US Rate Cut Hopes; Holly Futures Jumps 15%	Aug. 19	MT
HK stocks drift higher on US rate outlook; China banks hit record peaks	Aug. 19	RE
HK stocks drift higher on US rate outlook; China banks hit record peaks	Aug. 19	RE
JD Health International Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 15	CI
JD Health's H1 Profit Surges to 2 Billion Yuan	Aug. 15	MT
JD Health International Inc., H1 2024 Earnings Call, Aug 15, 2024	Aug. 15
JD Health International Inc. Announces Appointment of Professor George Lau as Independent Non-Executive Director	Aug. 15	CI
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	Jul. 17	MT
JD.com's Healthcare Arm Shuttering Family Doctor Initiative	May. 29	MT

Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	Nov. 18	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	Aug. 19	MT
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	Jul. 17	MT
Nomura Adjusts JD Health’s Price Target to HK$44 to HK$37, Keeps at Buy	Mar. 22	MT
Nomura Adjusts JD Health International’s Price Target to HK$44 from HK$60, Keeps at Buy	Jan. 19	MT

JD Health International Inc. Stock

Equities

6618

KYG5074A1004

Drug Retailers

Valuation: JD Health International Inc.

Chart: JD Health International Inc.

Latest news: JD Health International Inc.

Last Transcript: JD Health International Inc.

Analysts' recommendations: JD Health International Inc.

Press Releases: JD Health International Inc.

News in other languages: JD Health International Inc.

Quotes and Performance

Course Extremes

Managers and Directors: JD Health International Inc.

ETFs: JD Health International Inc.

Other Drug Retailers

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

JD com misses estimates quarterly sales	Aug. 15	AQ
JD.com verslaat verwachtingen	23-08-16	AQ
JD.com lacks estimates	23-03-09	AQ
JD Health International : Next Day Disclosure Return	22-06-01	PU
JD Health International : Next Day Disclosure Return	22-04-26	PU

Borse Cina : Hong Kong chiude a -0,85% con settore tech sotto pressione	Jan. 03
Las acciones de Hong Kong terminan a la baja en un clima de aversión al riesgo -- Market Talk	23-08-02
Point marchés-Peu de changements en vue en Europe en attendant la Fed (actualisé)	22-05-04
Les valeurs à suivre mardi 7 septembre à Wall Street -	21-09-07
JD.com : le fondateur prend du recul	21-09-07

1 day	-0.86%
1 week	+3.78%
Current month	+1.76%
1 month	+5.10%
3 months	+24.89%
6 months	+10.33%
Current year	-26.21%

Director	Title	Age	Since
En Lin Jin CEO	Chief Executive Officer	44	2021-09-05
Deng Hui DFI	Director of Finance/CFO	38	2023-05-10
Ming King Chiu SEC	Corporate Secretary	47	-

Manager	Title	Age	Since
Qiang Dong Liu CHM	Chairman	52	2020-09-13
Qing Qing Yi BRD	Director/Board Member	52	2020-08-20
Xing Yao Chen BRD	Director/Board Member	50	-

Name	Weight	AuM	1st Jan change	Investor Rating
KRANESHARES CSI CHINA INTERNET UCITS ETF - GBP	4.51%	16 M€	+17.21%	-
KRANESHARES CSI CHINA INTERNET UCITS ETF - EUR	4.51%	108 M€	+22.56%	-
LEVERAGE SHARES -3X SHORT CHINA TECH ETP SECURITIES - USD	4.41%	0 M€	0.00%	-
KRANESHARES CSI CHINA INTERNET UCITS ETF - USD	3.58%	346 M€	+16.87%

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
JD HEALTH INTERNATIONAL INC.	-0.86%	+3.78%	-21.28%	-53.28%	11.93B
WALGREENS BOOTS ALLIANCE, INC.	-0.33%	+2.52%	-56.95%	-80.77%	7.74B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-0.54%	-0.54%	-15.47%	-47.11%	7.6B
MATSUKIYOCOCOKARA & CO.	+4.79%	+7.60%	-9.76%	+55.38%	5.84B
CLICKS GROUP LIMITED	+0.59%	-0.15%	+35.33%	+35.54%	5.25B
NAHDI MEDICAL COMPANY	+2.35%	+5.36%	-10.57%	-	4.12B
YIFENG PHARMACY CHAIN CO., LTD.	-1.92%	+2.49%	-26.59%	-11.23%	3.9B
REDCARE PHARMACY NV	-0.42%	+6.50%	+21.67%	+8.83%	3.29B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-1.91%	-1.62%	+39.38%	+103.71%	3.15B
WELCIA HOLDINGS CO., LTD.	+1.49%	+3.97%	-21.92%	-49.10%	2.7B
Average	+0.36%	+2.84%	-6.62%	-4.23%	5.55B
Weighted average by Cap.	+0.28%	+3.12%	-12.51%	-18.08%

	2024 *	2025 *
Net sales	57.73B 61.67B 7.92B 7.54B 7.02B 6.26B 11.15B 671B 12.24B 87.3B 32.37B 275B 29.77B 29.11B 1,185B	64.84B 69.27B 8.9B 8.47B 7.89B 7.03B 12.52B 754B 13.75B 98.06B 36.36B 309B 33.44B 32.69B 1,331B
Net income	3.11B 3.32B 427M 406M 378M 337M 600M 36.15B 659M 4.7B 1.74B 14.82B 1.6B 1.57B 63.81B	3.55B 3.79B 487M 464M 432M 385M 685M 41.28B 753M 5.37B 1.99B 16.93B 1.83B 1.79B 72.85B
Net Debt	-19.12B -20.43B -2.62B -2.5B -2.33B -2.07B -3.69B -222B -4.05B -28.92B -10.72B -91.18B -9.86B -9.64B -392B	-23.71B -25.33B -3.25B -3.1B -2.88B -2.57B -4.58B -276B -5.03B -35.86B -13.3B -113B -12.23B -11.96B -487B